Screener
Arcutis Biotherapeutics, Inc. ARQT Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| Product revenue, net | $129,861 | $81,504 | $235,259 | $145,350 |
| Other revenue | — | — | — | 2,000 |
| Total revenues | 129,861 | 81,504 | 235,259 | 147,350 |
| Operating expenses: | ||||
| Cost of sales | 10,939 | 7,492 | 20,723 | 16,322 |
| Research and development | 20,355 | 19,453 | 50,982 | 36,996 |
| Selling, general and administrative | 82,138 | 69,170 | 156,214 | 133,172 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Arcutis Biotherapeutics, Inc.'s total revenue?
- Arcutis Biotherapeutics, Inc. (ARQT) reported total revenue of $129.86M in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s total revenue changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s total revenue increased by 59.3% year-over-year, from $81.5M to $129.86M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s total revenue?
- Over 3 years (2022 to 2025), Arcutis Biotherapeutics, Inc.'s total revenue has grown at a 367.3% compound annual growth rate (CAGR), from $3.69M to $376.07M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Arcutis Biotherapeutics, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude